| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.82▲ | 7.00▼ | 7.01▼ | 6.74▲ | 6.65▲ |
| MA10 | 6.87▼ | 7.09▼ | 7.07▼ | 6.63▲ | 6.02▲ |
| MA20 | 6.94▼ | 7.09▼ | 6.89▼ | 6.73▲ | 5.85▲ |
| MA50 | 7.08▼ | 6.80▲ | 6.66▲ | 5.95▲ | 4.43▲ |
| MA100 | 7.10▼ | 6.66▲ | 6.69▲ | 5.75▲ | 3.78▲ |
| MA200 | 6.91▼ | 6.72▲ | 6.30▲ | 4.47▲ | 3.32▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.010▼ | -0.049▼ | -0.018▼ | -0.008▼ | 0.055▲ |
| RSI | 33.624▼ | 41.726▼ | 49.305▼ | 58.647▲ | 60.735▲ |
| STOCH | 14.079▼ | 32.254 | 49.712 | 50.759 | 60.148 |
| WILL %R | -71.154 | -85.849▼ | -61.905 | -42.326 | -31.452 |
| CCI | -67.838 | -192.167▼ | -72.304 | 112.303▲ | 71.483 |
|
Thursday, February 19, 2026 05:22 AM
NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/02/26 | 7.04 | 7.30 | 6.765 | 6.845 | 1,050,095 |
| 19/02/26 | 6.69 | 7.17 | 6.53 | 7.15 | 777,347 |
| 18/02/26 | 6.54 | 6.75 | 6.51 | 6.67 | 534,668 |
| 17/02/26 | 6.48 | 6.59 | 6.25 | 6.55 | 640,469 |
| 13/02/26 | 6.55 | 6.815 | 6.46 | 6.51 | 253,126 |
| 12/02/26 | 6.46 | 6.69 | 6.32 | 6.53 | 316,225 |
| 11/02/26 | 6.47 | 6.6788 | 6.225 | 6.48 | 471,275 |
| 10/02/26 | 6.41 | 6.64 | 6.31 | 6.44 | 630,171 |
| 09/02/26 | 6.66 | 6.66 | 6.31 | 6.48 | 577,530 |
| 06/02/26 | 6.66 | 6.89 | 6.60 | 6.65 | 615,209 |
|
|
||||
|
|
||||
|
|